Logotype for Kyverna Therapeutics Inc

Kyverna Therapeutics (KYTX) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Kyverna Therapeutics Inc

Proxy filing summary

13 Apr, 2026

Voting matters and shareholder proposals

  • Election of two Class II directors, Ian Clark and Christi Shaw, to serve until the 2029 annual meeting.

  • Ratification of BDO USA, P.C. as independent auditor for the year ending December 31, 2026.

  • Proxies may vote on other business that arises during the meeting or any adjournment.

Board of directors and corporate governance

  • Board recommends voting in favor of both director nominees and the auditor ratification.

Audit committee and external auditor matters

  • Audit Committee selected BDO USA, P.C. as the independent registered public accounting firm for 2026.

  • Shareholders are asked to ratify this appointment at the annual meeting.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more